共 252 条
[1]
Chobanian AV(2003)National Heart, Lung, and Blood Institute Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2560-2572
[2]
Bakris GL(2000)Antihypertensive drugs as predictors of type 2 diabetes among subjects with impaired glucose tolerance Diabetes Res Clin Pract 50 231-239
[3]
Black HR(2012)Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2981-2997
[4]
Cushman WC(2003)A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial JAMA 290 2805-2816
[5]
Green LA(2011)Opposing effects of beta blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease Am J Cardiol 107 1705-1709
[6]
Izzo JL(1988)The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabetics Am Heart J 115 640-656
[7]
Rajala U(1991)Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism Diabetes Care 14 203-209
[8]
Qiao Q(2007)The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker Curr Med Res Opin 23 1239-1244
[9]
Laakso M(2004)Antihypertensive therapy and incidence of type 2 diabetes: a systematic review Diabetes Care 27 247-255
[10]
Keinänen-Kiukaanniemi S(2005)Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes J Hypertens 23 463-473